Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Wendy Silverstein Plans Exit From New York REIT - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VNO.PRH VNO.PRK VNO.PRL XKE VNO.PRF VNO.PRICL VNO.PRM BPY VNO VNO.WI VNORP CXP TRTX NYRT VNO.PRG VNO.PRI

1
WeWork Rival Convene Raises $152 Million to Fuel Its Expansion - Bloomberg

2018-07-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BCS.PRD BCS BCS.PRC BCS.PRA BPY CCV CMCSA CCZ 83SF BCS.PR BLK 83SK CCV.CL CMCSK 47MC

11
A Primer On Brookfield Asset Management

2018-07-09 seekingalpha
Brookfield (BAM), an under-the-radar company, is one of the largest alternative asset managers in the world.
BAMGF ADN BPY BBU SDSNQ ACAZF GGP.PRA SUNE BRK.A SUNEQ GLBL BIP GGP BAMKF BAM MKL TERP BEP

2
Brookfield Property Partners' Debt Is A Bit Too High For Me

2018-07-09 seekingalpha
BPY has a proven growth plan backed by a proven sponsor and trades at an attractive valuation.
BAMGF BPY BAMKF BAM

4
Why This Mortgage REIT Helps Me Sleep Well At Night

2018-07-05 seekingalpha
There could be value to the size of the circle, but an intelligent investor should pay close attention to the nucleus.
ARI BPY STWD PFE STWD.WI

7
Mid-Year REIT Market Update

2018-07-05 seekingalpha
Between the four REIT team members, we met with over 50 REIT management teams at the June REITWeek conference.
KRC.PRG BPY KRC.PRH DCT KRC BXP TCO KRG UDR LSI TRNO EQR MAC JCAP.PRB AVB REG.PRG REG.PRF VNO EQIX TCO.PRK TCO.PRJ FR FRT JBGS RVI JCAP SPG QTS WPG PEI REG DLR.PRH DLR.PRG DLR.PRJ DLR.PRI SKT CXP EXR CONE COR ESS GGP EGP DDR MNR ROIC UE RPAI PLD SPG.PRJ KRLP OFC IRT BXP.PRB REXR DLR LPT DLR.PRC WRI DLR.PRF ESRT

1
Brookfield Property Finance ULC Completes Medium Term Notes Issue for C$300 Million

2018-07-03 globenewswire
BROOKFIELD NEWS, July 03, 2018 (GLOBE NEWSWIRE) -- Brookfield Property Finance ULC, a subsidiary of Brookfield Property Partners L.P. (NASDAQ:BPY) (TSX:BPY.UN), announced today the completion of its Medium Term Notes, Series 1 issue (the “Notes”). The Notes will be fully and unconditionally guaranteed by Brookfield Property Partners and certain of its key holding subsidiaries. The Notes were offered by a syndicate of agents co-led by CIBC World Markets Inc.
BAMGF BPY BAMKF BAM

3
A Global Real Estate L.P. That Yields 6.4%

2018-07-03 seekingalpha
BAM is the external manger to BPY that was spun out in 2013 as the “everything real estate” holding company.
BAMGF SPG.PRJ BPY BBU SPG BIP GGP BAMKF BAM BEP GGP.PRA

54
Dividend Stocks Brought To You By 2018

2018-07-02 seekingalpha
While investing in dividend champions like Altria Group (MO), Procter & Gamble (PG), and AT&T (T) can be appealing, investors should diversify across several sectors. At The REIT Forum, we specialize in REITs.
BAMGF BPY NLY NLY.PRA NLY.PRECL NLY.PRD SUI.PRA NLY.PRE GGP.PRA NLY.PRC NLY.PRF NLY.PRG SUI AGNC GGP BAMKF BAM MO

7
Brookfield And GGP - A Brief Merger Arbitrage View With 1 Month Remaining

2018-06-29 seekingalpha
Prospective investors could take the attractive arbitrage return or back themselves into a reduced BPY cost basis.
BPY GGP

5
BPY / Brookfield Property Partners L.P. FORM 6-K (Current Report of Foreign Issuer)

2018-06-29 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
BPY

24
Brookfield Property Partners to Hold Conference Call & Webcast of Second Quarter 2018 Financial Results Wednesday, August 1, 2018 at 11:00 AM (ET)

2018-06-29 globenewswire
BROOKFIELD NEWS, June 29, 2018 (GLOBE NEWSWIRE) -- Brookfield Property Partners L.P. (NASDAQ:BPY) (TSX:BPY.UN) announced today that its second quarter 2018 financial results will be released before the market open on Wednesday, August 1, 2018. Analysts, investors and other interested parties are invited to participate in the company’s live conference call reviewing the results on Wednesday, August 1 at 11:00 AM (ET).
BAMGF BPY BAMKF BAM

5
BPY / Brookfield Property Partners L.P. 424B3 (Prospectus)

2018-06-27 sec.gov
424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-224594
BPY

77
Ain't Nothing Like The REIT Thing

2018-06-26 seekingalpha
REIT headwinds persist, including rising interest rates and bond yields, as well as the pro-growth, risk-on environment.
REG GEO BPY ARI EPR.PRG O.PRF OPRF KRG UMH.PRD UMH.PRC UMH.PRB UMH.PRA AI LADR EQR AI.PRB CORR.PRA GGP UMH AIW AVB CORR REG.PRG REG.PRF ARI.PRA NRZ ARI.PRC AIC O NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE GGP.PRA NLY.PRC NLY.PRF NLY.PRG EPR CBL

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: G16249107